Literature

Standardization

ADA, EASD, IFCC, IDF, 2007. Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement.
Diabetes Care 30: 2399-2400.

Little RR et al. 2001. The National Glycohemoglobin Standardization Program: A Five-Year Progress Report.
Clin Chem 47: 1985-1992.

The Diabetes Control and Complications Trial Research Group. 1993.The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.
N Eng J Med 329: 977- 986.

John G and English E 2012. IFCC standardised HbA: should the world be as one?
Clin Chem Lab Med 50: 1243–1248.

Hanas R and John G 2013. 2013 update on the worldwide standardization of the hemoglobin A measurement.
Clin Chem Lab Med 51: 1041–1042.

Advantages of HbA1c

Sacks DB. 2011. A1C Versus Glucose Testing: A Comparison.
Diabetes Care 34: 518-523.

HbA1c for Diagnosis

Mosca A et al. 2013. Glycemic control in the clinical management of diabetic patients.
Clin Chem Lab Med 51: 753-766.

World Health Organization (WHO) Report 2011. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus.

Lapolla A et al. 2011. The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: Still a long way to go.
Nutrition, Metabolism & Cardiovascular Disease 21: 467-475.

Late Diabetic Complications

Stratton et al. 2000. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
BMJ 321: 405-412.

No authors listed. 1998. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
The Lancet 352: 837-853.

Diabetes-associated Costs

Baechle CC et al. 2012. Costs of paediatric diabetes care in Germany: current situation and comparison with the year 2000.
Diabet Med 29: 1327-34.

Reese AB 2011. Innovative approaches to reduce diabetes costs.
N C Med J 72: 409-12.

Oglesby AK 2006. The association between diabetes related medical costs and glycemic control: A retrospective analysis. BioMed Central - Cost Effectiveness and Resource Allocation.